Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial - Rial-Crestelo, M; Lubusky, M; Parra-Cordero, M; RATIO37 Study Group (Lancet, 2024)
(10426):